Clinical trial
VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell…
NCT00274794 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00274794 |
|---|---|
| Title | VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL |
| Official title | A Prospective Randomized Trial of VP-16 Plus G-CSF Plus Rituximab vs VP-16 Plus G-CSF Alone for Peripheral Blood Progenitor Cell Mobilization Prior to Autologous Stem Cell Transplantation for B Cell Lymphoid Malignancies |
| Lead sponsor | The Cleveland Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological |
| Interventions | filgrastim, rituximab |
| Enrollment | 55 |
| Start date | Feb 1, 2000 |
| Primary completion | May 1, 2006 |
| Completion | May 1, 2006 |
| First posted | Jan 11, 2006 |
| Last update posted | Mar 29, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: